European Commission grants orphan status to nirogacestat
The drug is being developed for the treatment of soft tissue sarcoma
Read More
Tag: soft tissue sarcoma
Scotland approves three new meds for NHS use
The Scottish Medicines Consortium (SMC) has published new advice accepting three new medicines for use by NHS Scotland, offering patients new treatment options for soft tissue sarcoma, acromegaly and hepatitis C
Read More
NICE backs Lartruvo for soft tissue sarcoma
Patients with soft tissue sarcoma in England and Wales look set to win routine NHS access to Eli Lilly’s Lartruvo after cost regulators backed funding for the drug in draft guidelines.
Read More
Lilly’s Lartruvo get EU nod for soft tissue sarcoma
Eli Lilly’s Lartruvo has received a conditional marketing approval by the European Commission to treat soft tissue sarcoma (STS).
Read More
Lilly’s Lartruvo bags US nod for soft tissue sarcoma
Eli Lilly’s Lartruvo has been approved by the US Food and Drug Administration to treat soft tissue sarcoma.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
